28 September 2026
South Africa's pharmaceutical policy must weigh low medicine prices against sustaining local manufacturing and supply security.
9 September 2026
Aspen has abandoned local lenacapavir production, citing no guaranteed demand, and is backing Merck's alimatravir pill instead.
14 August 2026
Black-owned pharmaceutical companies urge the Health Department to revise its tenders, increase local support, and address market inequality.
7 August 2026
Local pharmaceutical manufacturing is under pressure as state tenders favour low prices, threatening jobs, medicine supply and investment.
11 June 2026
Learn how reliance on imported medicines threatens South Africa's jobs and the industry's pharmaceutical security.
10 June 2026
The lenacapavir HIV Prevention Injection rollout begins in SA, but activists warn that limited supply from Gilead could blunt the impact.
9 January 2026
HIV prevention in South Africa hinges on local drug manufacturing to ensure access, reduce delays, and enable regional health security.
6 November 2025
Understand the impact of stockouts on the South Africa TB epidemic and SANAC's strategies for effective solutions.